Topics | Cellgenetherapyreview.com

Charting a path with biomarker discovery tools
Tuesday, February 11, 2025
Biomarkers have become indispensable in the creation and optimization of cutting-edge treatments. read more
The biggest challenges in cell and gene therapy
Monday, February 03, 2025
To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more
2025 cell and gene challenges: Investment, technology and innovation
Monday, February 03, 2025
To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more
2025 cell and gene challenges: Thoughts from our editorial board
Monday, February 03, 2025
To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more
2025 cell and gene challenges: Scalability, supply chain and manufacturing
Monday, February 03, 2025
To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more
CGT top 10 storylines
Thursday, January 02, 2025
As we head into a new year, it’s time to look back at 2024 and appreciate the tremendous progress made in cell and gene therapy. read more
Switzerland: A rising hub for cell and gene therapies
Friday, December 13, 2024
With a well-established infrastructure that spans the entire pharma value chain from APIs to manufacturing, Switzerland is uniquely positioned to become a specialized hub for the most promising area of advanced medicine — cell and gene ... read more
FDA approvals for cell and gene therapies stay on track
Monday, November 25, 2024
The industry stays on track with FDA approvals for cell and gene therapies read more
Using rapid microbiological methods to ensure product safety
Friday, November 22, 2024
How flexible rapid testing can serve the different needs of cell and gene therapy manufacturers read more
Unlocking cell therapy’s potential
Friday, November 22, 2024
By continuing to crack the code of complex manufacturing, we can move closer to making long-lasting treatments affordable and available to all read more
Navigating the complexities of analytical validation for advanced therapies
Wednesday, November 20, 2024
Generating an analytical strategic plan and developing methods appropriately during process development will help ensure quality, safety and efficacy read more
Changing the model of care to advance CAR-T cell therapies
Wednesday, November 20, 2024
Autologous CAR-T cell therapies have already proven effective in treating hematological cancers, spurring extensive research into their potential for a wider range of diseases. read more

Subscribe to Magazine

Get started here for your complimentary print or digital subscription

Apr/May/Jun 2026 edition now available!
Get started here for your complimentary print or digital subscription
Sign up Now »

World Orphan Drug Congress USA 2026
June 9-11, 2026
BIO International Convention 2026
June 22-25, 2026
AAPS Summer Scientific Forum 2026
July 13-16, 2026